ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $47,749,000 | +63.1% | 3,838,376 | +79.5% | 4.12% | +76.8% |
| Q3 2016 | $29,276,000 | +25.9% | 2,138,471 | +69.2% | 2.33% | -33.5% |
| Q3 2013 | $23,258,000 | +4.1% | 1,264,009 | -1.0% | 3.50% | -11.0% |
| Q2 2013 | $22,337,000 | +51.2% | 1,277,109 | +56.3% | 3.94% | +45.2% |
| Q1 2013 | $14,770,000 | – | 816,909 | – | 2.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |